Rating Change
UBS analysts reiterated a Neutral rating on ArcBest Corporation (NASDAQ:ARCB) on August 03, 2026.
Rating Change UBS analysts reiterated a Neutral rating on ArcBest Corporation (NASDAQ:ARCB) on August 03, 2026. Market Context ArcBest Corporation operates in the Industrials…

UBS analysts reiterated a Neutral rating on ArcBest Corporation (NASDAQ:ARCB) on August 03, 2026.
ArcBest Corporation operates in the Industrials sector. The stock currently trades at $137.57 with a market capitalization of $2.3B.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for ArcBest Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 03, 2026 | UBS | Neutral | N/A |
| Jul 30, 2026 | TD Cowen | Hold | N/A |
| Jul 21, 2026 | Stifel | Buy | N/A |
| Jul 15, 2026 | Truist Securities | Buy | N/A |
| Jul 15, 2026 | Citizens | Market Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View ARCB Stock Page
A Neutral rating from UBS reflects the analyst's outlook on ArcBest Corporation (NASDAQ:ARCB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ARCB forecast page.
Current market data
NASDAQ · ARCB
$134.45
Up: +$1.57 · +1.17%
Live quote updated
Keep reading